Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Payout Powerhouses: 7 Dividend Stocks to Buy Now

Just like in arguably most sports, balance is everything. The same applies to dividend stocks to buy. Yes, the high-flying growth names tend to attract…

Why Is BioRestorative Therapies (BRTX) Stock Up 42% Today?

BioRestorative Therapies stock is up on Thursday with heavy trading of BRTX shares after announcing licensing negotiations.

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns

Wall Street says these three deeply discounted stocks for double-digit returns over the next year have an average implied upside of 83%.

Why Is Cara Therapeutics (CARA) Stock Down 27% Today?

Cara Therapeutics stock is down on Thursday as investors learn of a failed clinical trial and the company considering strategic alternatives.

Why Is Assure (IONM) Stock Down 53% Today?

Assure stock is down on Thursday as IONM investors react to the company terminating a merger agreement with Danam Health.

Why Is Longeveron (LGVN) Stock Up 46% Today?

Longeveron stock is up on Thursday with heavy trading of LGVN shares as the company's units continue to rally on clinical trial news.

Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June

Here are three dividend stocks to buy for your retirement portfolio that should offer rising income beyond the rate of inflation.

3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years

One of the best ways to spot winning stocks to buy is by spotting hot trends, such as artificial intelligence and obesity.

How to Invest in Penny Stocks in 2024: 3 Best Picks

For investors wondering how to invest in penny stocks, look no further! These three penny stocks all have serious growth potential.

Why Is Longeveron (LGVN) Stock Up 120% Today?

Let's dive into why shares of Longeveron are surging today, with LGVN stock nearly doubling today on some possible updates.

Blue-Chip Bonanzas: 3 Industry Leaders Trading at Unbelievable Discounts

When it comes to targeting discounted ideas in the equities sector, undervalued blue-chip stocks offer some of the most compelling prospects. First and foremost, blue…

4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024

Consider making moves in these securities, each of which has news that is impacting their share price either positively or negatively.

7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom

Because it’s tied to one of the six leading causes of “finality,” stress represents a silent public health crisis. And few things cause heightened stress…

3 Stocks Quietly Preparing for a 10X Surge: June Edition

There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia.

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?

Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares.

Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug

Eli Lilly stock is up on Tuesday as investors in LLY celebrate an FDA panel putting its support behind the company's Alzheimer's drug.

3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants

After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.

Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024

These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news

7 Over-Hyped Stocks to Sell Before They Plunge: June Edition

Although these popular names may be hot now, soon the market could agree that they are over-estimated stocks to sell.